Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
about
Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsHyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused OrgansMitochondrial fatty acid oxidation in obesityTreatment of nonalcoholic steatohepatitis in adults: present and futureNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineEnergy metabolism in the liverLow-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver diseaseMetabolically healthy and unhealthy obese--the 2013 Stock Conference reportUnderstanding cachexia as a cancer metabolism syndromeEffects of exercise training on intrahepatic lipid content in humansSirtuins and nonalcoholic fatty liver diseaseGlial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expressionIdentification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteinsSIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylaseMechanisms for insulin resistance: common threads and missing linksDevelopmental origins of NAFLD: a womb with a clue.Promising therapies for treatment of nonalcoholic steatohepatitis.Hepatic glucose and lipid metabolism.Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid accretion by whey protein ingestion?Mechanisms of Liver Injury in Non-Alcoholic SteatohepatitisER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Approach to assessing determinants of glucose homeostasis in the conscious mouseRole of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver DiseaseSystematic analysis of the gene expression in the livers of nonalcoholic steatohepatitis: implications on potential biomarkers and molecular pathological mechanism.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsInfluence of liver triglycerides on suppression of glucose production by insulin in men.Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.Increased gluconeogenesis in youth with newly diagnosed type 2 diabetesKetogenesis prevents diet-induced fatty liver injury and hyperglycemiaNeuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsDipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.Physiology and pathophysiology of liver lipid metabolism.In an Ovine Model of Polycystic Ovary Syndrome (PCOS) Prenatal Androgens Suppress Female Fetal Renal GluconeogenesisHepatic Steatosis as a Marker of Metabolic Dysfunction.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesMass spectrometry-based microassay of (2)H and (13)C plasma glucose labeling to quantify liver metabolic fluxes in vivo.Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease
P2860
Q26751258-BCFD663B-D706-4E5F-8556-641ED88BAEE4Q26781659-0E0F2783-FEF4-402E-A209-C3B5A02965F1Q26820838-2888F957-B220-4230-9C32-C4453E6BB724Q26852403-7FDBAAB9-63C1-406F-AC4D-24ACE269C494Q26992163-B6658DC5-6F84-4EB2-904B-E75619289513Q26996783-BD287BE6-3292-4A29-A39A-5CB2EAC81C13Q27007233-31998D21-2B66-4874-9882-F30B3EF4D250Q27021552-BE77A220-ABC5-4A33-9343-3812F23D6CE0Q28069390-5B180C27-A8AB-4896-95F5-5D9D5DA0B288Q28071597-9F8D9BF9-7C9F-41F6-9BB9-7E4DE89784EDQ28079953-8102264B-350E-4C69-A534-C611B917C77BQ28354027-97EBF6F5-7801-436A-8C97-23FA9F3EA493Q28488095-B8529430-1502-45C0-A7C4-5DBC85F6A4AAQ28506154-E01CE892-5BD7-4525-8E46-24EC8E9549A2Q29620447-B94F2CA9-7440-4AEA-B350-50CF0F9D0A3CQ30241940-69382BB4-9C52-4112-AA13-B603F354E3B5Q30248578-2F8BCC77-7F88-4C12-8D75-C7FE541588DEQ31069203-BAA29084-6D2C-44E2-B30B-667440F1BA1CQ33709740-E37F3D75-2974-40CE-A725-2CFDD4876DE3Q33898945-FDF0F47E-6D27-431E-81A7-EB45458BF9A9Q33906433-128D18AC-9422-4739-9471-780117C2542EQ33958697-ABA2BDEB-0F2B-4192-B5DF-E844E3378C61Q34205173-5D87A51D-6840-4542-AA7F-706E0098135AQ34302360-FA83E122-9761-4A95-B208-D58BD8D1BB7CQ34522557-7C73CF7C-A332-4367-A76A-41A9B8B78756Q34540092-4F85AAEE-CCB5-4C41-9F9A-9EE6808C39EAQ34800989-563827CA-1A84-467F-9B49-E22C9F60DF78Q34810790-2B31424C-79FA-49A2-B52A-ECBF2A6FE620Q34979884-003F334C-4E9C-4793-990B-024A5C846417Q35071262-DB193F2E-4673-41FB-9BCB-5D8F3F849765Q35145496-7F07D364-EC0D-43E2-87BF-EF34FB06D6CAQ35559692-ECC1C25D-A103-492D-9766-F2EAA8123E35Q35630861-BE6A606B-0665-422A-AEE0-3305B83739CEQ35662655-2433E9C4-0CB9-454B-9BD9-3B30807C9CB6Q35684227-FDB8CAE0-22D0-4F44-BDEE-1E9770CEFC97Q35809069-075BA3FD-9A7C-4750-8618-6694EF9331DFQ35811523-CD694FCC-19A8-40CE-B174-C1F0DADFA89EQ35859172-FF61C1A6-BBE8-41D2-97BE-1F75882D0DA7Q35958436-262119F2-DF6B-41A9-B506-8A585247F30DQ35958498-7BB6A3BD-0456-4B20-A300-0F0E39A6EAEE
P2860
Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Excessive hepatic mitochondria ...... nalcoholic fatty liver disease
@en
type
label
Excessive hepatic mitochondria ...... nalcoholic fatty liver disease
@en
prefLabel
Excessive hepatic mitochondria ...... nalcoholic fatty liver disease
@en
P2093
P2860
P1433
P1476
Excessive hepatic mitochondria ...... nalcoholic fatty liver disease
@en
P2093
Jeffrey D Browning
Nishanth E Sunny
Shawn C Burgess
P2860
P304
P356
10.1016/J.CMET.2011.11.004
P577
2011-12-01T00:00:00Z